Systemic thrombolysis and endovascular thrombectomy in severe acute ischemic stroke after dabigatran reversal with idarucizumab

Patients presenting with an acute ischemic stroke despite dabigatran therapy (last intake <24 h or unknown) should be evaluated for reversal by idarucizumab, making them eligible for safe and effective intravenous thrombolysis. It has been shown to be feasible, well‐tolerated, and easy to manage...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Case Rep
Main Authors: Binet, Quentin, Hammer, Frank D., Rocrelle, Olivia, Peeters, André, Scavée, Christophe, Hermans, Cedric
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Case Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889252/
https://ncbi.nlm.nih.gov/pubmed/29636943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1446
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki